Bempedoic Acid Tablet

DRUG2 trials

Sponsors

Gan & Lee Pharmaceuticals., CSPC Ouyi Pharmaceutical Co., Ltd.

Conditions

Primary Hyperlipidemia

Phase 3

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

RecruitingNCT06780410

Gan & Lee Pharmaceuticals.Primary Hyperlipidemia

Start: 2024-12-20End: 2025-10-31Target: 240Updated: 2025-01-17

A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid

Not yet recruitingNCT07623915

CSPC Ouyi Pharmaceutical Co., Ltd.Primary Hyperlipidemia

Start: 2026-06-12End: 2027-08-28Target: 222Updated: 2026-06-03